Technology | September 10, 2009

FDA Clears Asymptomatic Heart Failure Detection Device

September 10, 2009 – NI Medical Ltd. said yesterday it received FDA approval for its NICaS CS, a new device for the assessment of left ventricular systolic dysfunction (LVSD), to detect heart failure in its preclinical, asymptomatic phase.

The NICaS device uses impedance technology for measuring cardiac output, cardiac index, cardiac power, stroke index, total peripheral resistance, etc. This company said the device offers accurate results with a bioequivalence with the thermodilution technique.

It uses a new algorithm, the Granov Goor Index (GGI), which allows primary care physician to detect the LVSD asymptomatic phase during an ordinary physical examination.

The GGI may help in diagnosing a fraction of patients who will suffer sudden cardiac death (SCD). Of the total 650,000 annual deaths from coronary heart disease in the United States, approximately 350,000 succumb to SCD. The main cause of SCD, a condition called hibernating myocardium, accounts for approximately 35-40 percent of the 350,000 cases of SCD.

“By detecting these ‘hibernating’ cases in a timely manner, most of the lives of these individuals can be saved,” said Daniel Goor, M.D., chairman and chief investigator at NI Medical.

To use the NICaS, a doctor, nurse, or medical technician simply places one double electrode on the patient’s wrist and one on the ankle. The patient does not need to undress or be shaved. The entire process takes three to four minutes.

The NICaS electrodes are connected to the impedance device, which is situated within a laptop computer in place of the CD-ROM, and the laptop’s screen serves as the monitor.

The Framingham Study determined the diagnostic parameters of the so-called asymptomatic LVSD in 2003. It was because of the high economic burden of screening the population for the treatment of this malady that this enterprise was abandoned. However, with the advent of the GGI, the company said the nominally-priced NICaS CS ca diagnose at least 40 percent of asymptomatic LVSD cases.

For more information: www.nimedical.co.il

Related Content

Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Study Shows Multiple Benefits of Patient-to-Patient Connectivity in Familial Chylomicronemia Syndrome
News | Cardiac Diagnostics | August 07, 2018
Akcea Therapeutics Inc., an affiliate of Ionis Pharmaceuticals Inc., announced the publication of results from the...
Being Overweight May Change Young Adults' Heart Structure, Function
News | Cardiac Diagnostics | August 03, 2018
Even as a young adult, being overweight may cause higher blood pressure and thicken heart muscle, setting the stage for...
High Intensity Exercise in Teenagers Could Ward Off Heart Disease

Ultrasound image of the carotid artery. Lines in yellow were used to determine arterial diameter and stretching before and following exercise.

News | Cardiac Diagnostics | July 16, 2018
New research published in Experimental Physiology has indicated potential differences in heart health benefits of...
News | Cardiac Diagnostics | June 14, 2018
A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the...
The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.

 

Feature | Cardiac Diagnostics | May 07, 2018 | Steven D. Freedman, M.D., Ph.D.
 
Overlay Init